Summary Benzo(a)pyrene and benzene are human carcinogens. The metabolic activation of these compounds into ultimate mutagenic and carcinogenic metabolites is prerequisite for their carcinogenic effects. In this report. the mutagenicity and carcinogenicity of hydroquinones of benzo(a)pyrene and benzene was investigated to address two important questions: (1) do hydroquinones contribute to benzo(a)pyrene and benzene carcinogenicity: and (2) how safe is it to increase the levels of NAD(P)H:quinone oxidoreductase 1 (NO01). a key enzyme in the generation of hydroquinone. The supFtRNA of the plasmid pSP189 was used as the mutational target in a cell-free and Chinese hamster ovary (CHO) cell system to study hydroquinone mutagenicity. RNA and protein-free pSP189 DNA was incubated in a cell-free system with benzo(a)pyrene-3,6-quinone and purified NO01 or with benzoquinone hydroquinone to generate adducted pSP189 DNA IGelboin. 1980). The most studied metabolite of benzowapyrene is benzo a)px-rene-7.8-dihx drodiol-9. 1 0-epoxide BPDE). BPDE is know-n to bind w-ith DNA and cause G-sT transversions. leading to carcinogenicitv- (Jernstrom and Graslund. 1994 Correspondence to: AK Jaiswal and benzene generates a common class of compounds. quinones (Gelboin. 1980 : O'Brien. 1991: Hiraku and Kauwanishi. 1996. In addition to the benzowapyrene quinones and benzoquinones. a xariety of other quinones (e.g. naphthoquinones. tocopherol) are highlx abundant in nature (Chesis et al. 1984 Monks et al. 1992 : Talalay et al. 1995 . The difference betu-een the tu-o-electron and one-electron reduction pathways for quinones is that the latter. and not the former. pathu-av aenerates semiquinones and reactixe oxygen species of known toXicitv and mutagenicitv (O'Brien. 1991 : Monks et al. 1992 : Talalay et al. 1995 . For this reason the tu-o-electron reduction pathw-av of consversion of quinones to hydroquinones by NQO 1 is considered protectis e to the cells against the one-electron reduction pathw ay cons-erting quinones to semiquinones and then to the hydroquinones. In fact. NQO1 has been show-n to compete w ith P450 reductase for metabolic conversion of quinones to hydroquinone. resulting in protection to the 312
carcinogenesis
Exposure to environmental chemical carcinogens [e.g. benzoa)pxyrene and benzene] is know n to cause numerous human cancers (Harm's. 1991 ) . Benzo a)pyrene and benzene are procarcinogens that require metabolic activation to exert their mutagenic and carcinogenic effects (Gelboin. 1980) . Benzoa)pxyrene undercoes oxidatix-e metabolism to renerate more than 25 metabolites IGelboin. 1980) . The most studied metabolite of benzowapyrene is benzo a)px-rene-7.8-dihx drodiol-9. 1 0-epoxide BPDE). BPDE is know-n to bind w-ith DNA and cause G-sT transversions. leading to carcinogenicitv- (Jernstrom and Graslund. 1994) . These obsernations. although establishing an important role for BPDE in benzo(a)pyrene carcinogenicity. also raised interesting questions regarding the role of metabolites other than BPDE in benzo4 a)pyrene mutagenicity and carcinogenicitx. In addition. the metabolites of benzene responsible for benzene carcinogenicitV remain to be identified. Oxidative metabolism of benzo(a pyrene and benzene generates a common class of compounds. quinones (Gelboin. 1980 : O'Brien. 1991 : Hiraku and Kauwanishi. 1996 . In addition to the benzowapyrene quinones and benzoquinones. a xariety of other quinones (e.g. naphthoquinones. tocopherol) are highlx abundant in nature (Chesis et al. 1984) . Therefore. human exposure to quinones is extensive. The quinones are highlv reactive molecules that undergo further metabolism by one-step two-electron reduction [catalx-sed bv NAhAD P)H:quinone oxidoreductasel (NQO )] or tu-o-step one-electron reduction [catalx-sed by NADPH:cvtochrome P450 reductase (P450 reductase)] (O'Bnren. 1991: Monks et al. 1992 : Talalay et al. 1995 . The difference betu-een the tu-o-electron and one-electron reduction pathways for quinones is that the latter. and not the former. pathu-av aenerates semiquinones and reactixe oxygen species of known toXicitv and mutagenicitv (O'Brien. 1991 : Monks et al. 1992 : Talalay et al. 1995 . For this reason the tu-o-electron reduction pathw-av of consversion of quinones to hydroquinones by NQO 1 is considered protectis e to the cells against the one-electron reduction pathw ay cons-erting quinones to semiquinones and then to the hydroquinones. In fact. NQO1 has been show-n to compete w ith P450 reductase for metabolic conversion of quinones to hydroquinone. resulting in protection to the cells (Joseph and Jaiswal. 1994). The above observations have led to the discovery of natural and synthetic inducers of the NQOI gene. to increase the chemoprotective capacity of cells against exposure to quinones and related compounds (Prochaska et al. 1992; Zhang et al. 1992) .
In this report. we have investigated the mutagenicity and carcinogenicity of hydroquinones to address two important questions: (1) do hydroquinones contribute to benzo(a)pyrene and benzene carcinogenicity: and (2) how safe is it to increase the levels of quinone detoxifying enzyme (NQO1). which catalyses conversion of quinones to hydroquinones. The ).
Mutational analysis Cell-free system
The supF tRNA of the plasmid pSP189 was used as the mutational target to study hydroquinone mutagenicity by procedures as described previously (Kraemer and Seidman. 1989; Paris and Seidman. 1992) . Briefly. RNA and protein-free pSP189 DNA was prepared using the Qiagen plasmid preparation kit by the procedure as described in the manufacturer's instruction manual. The DNA was further cleaned with phenol-chloroform and ethanol precipitation by standard procedures (Sambrook et al. 1989 ). An aliquot of 10 gg of pSP189 DNA was incubated with 15 gM benzo(a)pyrene-3.6-quinone in the absence and presence of ten units of purified human or rat NQO I activity under the conditions as described by us previously to generate BP-3.6-HQ and DNA adduct formation LB plates containing 50 jgc ml-' ampicillin. 20 jg¢ ml-' 5-bromo-4-chloro-3-indolyl P-D-galactoside (X-gal) and 100 jg ml-' isopropyl >-E-thiogalactoside (IPTG) were selected and regrown on fresh plates. The plasmid DNA from the mutants was isolated and purified by the alkaline lysis procedure (Sambrook et al. 1989) . The SupF tRNA region of pSP189 isolated from mutant colonies was sequenced using the sequenase version 2.0 DNA sequencing kit. It may be noteworthy that every mutation was selected from a single transformation to avoid sibling formation.
Chinese hamster ovary (CHO) cell system Development of CHO cells permanently expressing high levels of microsomal P450 reductase or cytosolic NH01 ac.vity. Human cDNAs encoding cytosolic NQOI and microsomal P450 reductase have been cloned and sequenced (Jaiswal et al. 1988 : Yamano et al. 1989 . Human cDNAs for NQOI and P450 reductase were separately subcloned in pED6 vector to generate pED6-NQOl and pED6-P450 reductase plasmids (Kaufman et al. 1991) . The CHO cells were transfected with pED6-P450 reductase or pED6-NQOl recombinant plasmid and selected in the presence of increasing concentrations of methotrexate by procedures as described previously (Kaufman et al. 1991) . The selected clones were analysed for NQO1 and P450 reductase activities by procedures as described previously . The clone designated as CHO (NQOI) selected for overexpression of cDNA-derived NQOI expressed 1367-fold higher levels of NQO1 activity than the untransfected/ vector transfected control CHO cells. Similarly. the selected clone CHO (P450 reductase) expressed 34-fold higher levels of cDNAderived microsomal P450 reductase as compared with control CHO cells. The control CHO (wild type). CHO (NQOl ) and CHO (P450 reductase) were used in hydroquinone mutagenesis studies.
Monolayers of CHO (wild type). CHO (NQOO1) and CHO (P450 reductase) were transfected with pSP189 vector DNA by the calcium phosphate co-precipitation procedure (Kraemer and Seidman. 1989) . The transfected cells were grown in the medium containing 30 jM BP-3.6-Q for 4 h. Forty-eight hours following, the transfection. the shuttle vector DNA was rescued and the supF tRNA gene analysed for mutation as described under the in vitro mutation studies.
Hydroquinone carcinogenicity Transforrnation of BALBc/3T3 cells The transformation of BALBc/3T3 cells by hydroquinone was studied by a previously described procedure (Sakai et al. 1995) .
Britsh Jounnal of Cancer (1998) 78(3), 312-320 0 Cancer Research Campaign 1996 Table 1 Frequency of benzo(a)pyrene-3.6-hydroquinone (BP-3.6-HQ)-and benzoquinone hydroquinone (HOs)-induced deleton of a single cytosine from sequence 5'-172-CCCCC-176-3' of the pSP189. Note that mutational spectra other than deletion of a single cytosine in all the cases were similar to the spontaneous mutations and are shown in Table 2 .-Cell-free system. The plasmid pSP189 containing the mutational target supFtRNA gene was incubated with DMSO (spontaneous mutations) or BP-3.6-0 (15 gM) in absence and presence of purified human and rat NQO1 (5 jg) and superoxide dismutase (SOD) and catalase as indicated. In related experiments, the BP-3.6-0 was replaced with 15 gM HO. Hydroquinone-induced mutatins in the supFtRNA region were determined by procedures as described in Materials and methods. The purified human and rat NO01 were obtained from Dr David Ross, School of Pharmacy, Denver. CO. USA. Both human and rat NQO1 enzymes are known to catalyse high-affinity reducbon of BP-3, 6-0 to BP-3,6-HO. :CHO cell system. The Chinese hamster ovary (CHO) cells (wild type) expressing endogenous levels of cytosolic NQO1 and microsomal P450 reductase and the CHO cells permanentty expressing either 1 367-fold higher level of cDNA derived cytosolic NQO1 (NO01) or 34-fold higher levels of cDNA derived microsomal P450 reductase (P450 reductase) were transfected with pSP189 plasmid in separate experiments. The transfected cells were treated with DMSO (control) or with BP-3,6-O. NQO1 catalyses two-electron reducton of BP-3.6-Q (quinone) to BP-3,6-HO (hydroquinone). P450 reductase catatyses one-electron reductive activation of BP-3,6-Q (quinone) to BP-3.6-SQ (semiquinone) and ROS (reactive oxygen species). The metabolites thus generated bind to the plasmid pSP1 89, resutting in the formation of DNA adducts leading to mutagenicity. Mutational spectra in each case was determined as described in the text. Analysis of p53 and Ha-ras genes in the transformed
BALBcI3T3 foci
The HQ-and HQ+TPA-transformed foci of the BALBc/3T3 cells w-ere individually transferred into 24-w ell plates and further expanded. Genomic DNA from the various foci was isolated by the procedure as described (Laird et al. 1991 ). This DNA w-as used as template to amplify the p53 (exons 5-8) and the Ha-ras (exons 1 and 2) genes using polyImerase chain reaction (PCR). Exons 5-8 of the p53 tumour suppressor-gene were sequenced individually using the exon-based primers under the conditions as described (Goodrow et al. 1992 A-iT Mutation frequencies of benzo(a)pyrene-3.6-quinone (BP-3.6-Q); benzo(a)pyrene-3.6-semiquinone + reactive oxygen species (BP-3,6-SQ + ROS) and benzo(a)pyrene-3,6-hydroquinone (BP-3,6-HQ) in a cell-free system. The plasmid pSP189 containing the mutational target SupF tRNA was incubated with DMSO (spontaneous mutations) or with COS1 cell extract expressing 68-fold higher levels of cDNA-derrved cytochrome P450 reductase (BP-3.6-semiquinone + ROS induced mutations) or with punfied human or rat NQ01 (hydroquinone-induced mutations). The experiment with purified NQ01 (hydroquinone mutagenicity) was also performed in the presence of SOD and catalase. Mutations in each case were detected by the procedures as described in Materials and methods. A total of 40 mutants was sequenced in each set. Frequency of mutations are shown per million transformants. HDTD. human DT diaphorase (NO01): RDTD. rat DT diaphorase (NO01).
described procedure usina the primers and PCR conditions as ci-en below (Colapietro et al. 1993 ):
Primer 1. 5'-ATCACAGAATACAAGC1TGTGG-3' Primer 2. 5'-CTGTACTGATGGATGTCCTC-3' The PCR conditions involved 30 cvcles of denaturation at 94-C for 1 min. annealinrt at 58-C for 2 mn and extension at 72-C for 2 min follow-ed bv an extension of 7 min at 72'C.
The PCR products were analysed on 1 % agarose gel and subcloned immediatelv into the PCR 2.1 vector of the TA clonin2 kit (Invitrogen. San Diego. CA. USA) and used to transform competent E. coli cells according to the protocols of the manufacturer.
DNA was isolated from the transformants and sequenced using the sequenase version 2.0 DNA sequencing kit. The primers used to sequence the exon 1 and exon 2 of the Ha-ras gene w-ere the same as reported (Colapietro et al. 1993 ).
RESULTS
The results on BP-3.6-HQ-and HQ-induced mutations from the studies using a cell-free system are reported in Tables 1 and 2 . The spontaneous mutation frequency of pSP 189 plasmid DNA treated w-ith DMSO was 1.11±0.02 per million transformants in the cellfree svstem and 1.31+0±06 per million transformants in the CHO cell system (Table 1 ). The total mutation frequencies in both the systems increased twofold in the presence of BP-3.6-Q. P450 reductase but not NQO 1 further increased the total mutation frequency by 2'5-fold as compared with BP-3.6-Q (Table 1) . Inclusion of superoxide dismutase and catalase (scavengers of ROS) w ith NQO 1 had no effect on total mutation frequency obserxed with BP-3.6-Q + NQO1 (Table 1) . Analysis of the mutation spectra revealed that all the mutations except deletion of one cytosine from the sequence 5'-172-CCCCC-3' were more or less similar to the spontaneous (DMSO) mutations. It may be noteworthy that hydroquinone-induced deletion of a single cytosine may have been the result of deletion of a single guanosine in the complementary strand. The deletion of cytosine from a stretch of fixve cvtosines was not observed in spontaneous mutations and in the mutations caused by quinone (BP-3.6-Q) and P450 reductaseactivated quinone BP-3.6-Q (BP-3. 6-semiquinone and reactive oxy gen species) (Figure 1 . Tables 1 and 2 . Howexer. the deletion of one cy-tosine from 5'-CCCCC-3' w-as observed w-ith BP-3.6-HQ. (Tables 1 and 2 ). The nucleotide sequence of supF tRNA region of plasmid pSPl 89 and the HQ-induced deletion of one cytosine from a stretch of fixve cyVtosines are show n in Figure 1 . Similar results as described above with the cell-free svstem A-ere also observed in in xvivo mutagenesis experiments as show-n in Tables 1 and 3 . The CHO (A-ild type) cells expressing, loxw (endogenous) lex els of NQO 1 and P450 reductase. the CHO INQOI cells permanently expressing 1367-fold higher lexels of cDNA-derived human NQOO and the CHO (P450 reductase) cells permanently expressing, 34-fold higher lexels of cDNA-deri-ved human P450 reductase were transfected w-ith pSP189 plasmid followed by treatment with BP-3.6-Q. Mutational spectra in each case w-ere determined by standard procedures (Kraemer and Seidman. 1989: Pairs and Seidman. 1992 Mutation frequencies of benzo(a)pyrene-3.6-quinone (BP-3.6-Q). benzo(a)pyrene-3.6-hydroquinone (BP-3,6-HQ) and benzo(a)pyrene-3.6-semiquinone + reactive oxygen species (BP-3,6-SQ + ROS) as determined by using CHO cell system. The Chinese hamster ovary (CHO) cells (wild type), CHO cells expressing 1 367-fold higher levels of cDNA-denved human N001 and CHO cells expressing 68-fold higher levels of cytochrome P450 reductase were transfected with plasmid pSP1 89. The transfected cells were treated with either DMSO (control) or benzo(a)pyrene-3,6-quinone (BP-3.6-O). The mutational spectra generated due to DMSO (spontaneous) and metabolites of BP-3.6-Q were determined by procedures as descnbed in Materials and methods. Mutation frequencies are shown per million transformants.
Interestingiv. all of the 24 BALBc/3T3 foci selected w-ith hvdroquinone+TPA produced subcutaneous tumours in SCID mice (Figure 3) with BP-HQ and HQ above the level of spontaneous mutations was deletion of a single cytosine from sequence 5'-CCCCC-3'. The stretch of four cytosines and guanosines within the supF tRNA region was not targeted by BP-HQ and HQ. Secondly. two different hydroquinones (BP-HQ and HQ) showed similar mutations involving deletion of a single cytosine with significant frequencies (Table 1) . Lastly. hydroquinone-induced deletion of C from sequence 5'-CCCCC-3' was not detected in spontaneous mutations and in mutations induced by unmetabolized quinones and P450 reductase-activated products of quinones (semiquinones and reactive oxygen species).
The HQ treatment of BALBc/3T3 cells resulted in cellular transformation. which was significantly increased by tumourpromoting agents (TPA). The hydroquinone + TPA-transformed BALBc/3T3 cells produced fast-growing tumours in SCID mice. These results suggested that hydroquinones possess initiating capacity and require tumour promoters for complete transfonnation of cells leading to the development of fast-growing tumours. The various results also suggest that hydroquinone possesses much weaker initiating activity than 3-MC. Figure 4 Model for benzo(a)pyrene hydroquinone and benzoquinone hydroquinone mutagenicity and carcinogenicity. Benzo(a)pyrene quinones and benzoquinones eiter directly or after reductive metabolism by P450 reductase into products (semiquinones and reactive oxygen species) bind with the DNA and cause mutations. On the other hand, NO01 comnpetes with P450 reductase and catalyses the formaion of hydroquinones. It may be noteworthy that sefmiunones generated dunng P450 reductase-stmulated redox cycig may also be converted to hydroquinone by a second eectron reducton. This is especialy the case in the absence of oxygen. Hyroquinones corjuate with UDP-gucuronic acid, giutathn and suphate, leading to their excretion from the cells. The variou conjugation reacbons are catalysed by UDPG-bansferase (UDPGT), gutathione S-transferase (GST) and su4hotransferase (ST) . Therefore, the NOO1 pathway protects the cells from adverse effects of semiqum re and reactive oxygen species by preventing their formation. However, hydroquinones produced during the metaboic reducto of quaioies by N001, if not conqugated with glutthione or UDP-lucuronic acid and excreted from the cells, cause frameshift mutabons involvi deleton of a sxgle cytosine from sequence 5'-CCCCC-3. This type of mutaton was not observed with quinones, semiquinones and reactve oxygen species. Therefore, the delebon muttion of a single cytosine from sequence 5'-CCCCC-3' is specificaly associated with hydroquinones. In addition, the hydroquinones in assocation with tumour promoters transformed normal cells to malignant ceNs leading to tumour fornation Hydroquinoreinduced mutagenicity and carcinogenicity 319
Based on previous studies and results presented in the present report. a model to demonstrate the generation. detoxification and mutagenicity/carcinogenicity of hydroquinones of benzo(a)pyrene quinones and benzoquinones is presented in Figure 4 . Hydroquinones are generated by two-electron reduction of quinones catalysed by NQO1. They are more stable than the semiquinones. They conjugate with glutathione and UDP-glucuronic acid, leading to their excretion from the cells (Lind et al. 1982) . Therefore. the generation of hydroquinones within cells is a mechanism to protect them from the adverse effects of quinone exposure. Paradoxically. hydroquinones are mutagenic and carcinogenic as demonstrated in the present study. Hydroquinones caused sequence-specific frameshift mutations involving the deletion of a single cytosine from the sequence 5'-CCCCC-3'. In association with tumour promoters, hydroquinones transformed the cells with high efficiency and led to development of fast-growing tumours. These results with hydroquinones raised three important questions: (1) how safe is it to detoxify quinones by its conversion to hydroquinones mediated by NQO1: (2) are all the hydroquinones mutagenic and carcinogenic: and (3) which growth regulatory genes are mutated by HQ resulting in fast-growing tumours in SCID mice.
In response to the first question. it appears to be quite safe to detoxify quinones by NQO1-mediated conversion of quinones to hydroquinones. provided hydroquinones are removed by conjugation reactions as shown in the model in Figure 4 . This is also supported by the fact that chemopreventive agents (e.g. antioxidants and vitamins) not only induce the expression of the NQOI gene but also coordinately induce the expression of hydroquinone conjugating enzymes. glutathione S-transferase and UDPG-transferase (Rushmore and Pickett. 1993: Jaiswal. 1994 ). However. this scenario could be very different in cases in which the expression of conjugating enzymes is lost or lowered as a result of mutations. etc. The question regarding mutagenicity of various kinds of hydroquinones will require further study. Based on their ring structures, three different kinds of hydroquinones have been suggested (Cadenas. 1995) . These include: (1) redox-stable hydroquinones: (2) redox-labile hydroquinones that subsequently auto-oxidize to generate reactive oxygen species: and (3) hydroquinones that rearrange to potent electrophiles resulting in alkylation of DNA.
Because BP-3.6-HQ-induced mutations were unaffected by scavengers of reactive oxygen. the hydroquinones of benzo(a)pyrene quinones and benzoquinones used in the present studies may belong to the first and third category. The identification of genes targeted by HQ will also require additional work. A high percentage of tumours is known to arise from chemically induced frameshift mutations. as well as base substitutions. in a number of oncogenes and tumour-suppressor genes (Balmain and Brown. 1988: Hollstein et al. 1991; Beroud et al. 1996) . Thirty-seven per cent of human p53 mutations are caused by deletion and insertion of bases leading to frameshift mutations (Hollstein et al. 1991) . Similarly the Ha-ras gene has been shown to be the target of chemical mutations (Harris. 1991) . Therefore. we sequenced the p53 (exons 5-8) and Ha-ras (exons 1-2) genes in all 24 of the hydroquinone+TPA-transformed and one hydroquinone-transformed foci. The sequencing results failed to show any kind of (base substitution and/or insertion or deletion) mutation in the p53 and Ha-ras genes in these foci, indicating that some other growthregulatory genes may be involved. A search of the GenBank database for the presence of a hydoquinone specific sequence 5'-CCCCC-3' revealed that a large number of genes contain this sequence. Therefore. it is difficult to predict which genes may have been mutated in hydroquinone-transformed cells and tumours. Future experiments are required to identify these genes and to determime if mutations are due to the deletion of cytosine.
In conclusion. we have shown that: (1) environmentally abundant hydroquinones of benzo(a)pyrene quinones and benzoquinones cause specific mutations involving deletion of one cytosine from DNA sequence 5'-CCCCC-3' or one guanosine from the sequence 5'-GGGGG-3': (2) hydroquinones function as initiators of carcinogenesis: (3) hydroquinones in association with tumour promoters transform normal cells to malignant cells leading to fast-growing tumours; and (4) benzo(a)pyrene and benzene carcinogenicity may be due in part to their hydroquinone metabolites. ABBREVIATIONS NQOI. cytosolic NAD(P)H:quinone oxidoreductase 1 or DT diaphorase: P450 reductase. microsomal NADPH:cytochrome C reductase: SOD, superoxide dismutase: BP. benzo(a)pyrene: BPQ. benzo(a)pyrene quinone; BP-3.6-Q. benzo(a)pyrene-3.6-quinone: BP-3.6-SQ. benzo(a)pyrene-3.6-semiquinone; BP-3.6-HQ. benzo(a)pyrene-3.6-hydroquinone: BQ. benzoquinone: HQ. benzoquinone hydroquinone: ROS. reactive oxygen species.
